Elevated von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome

International Journal of Hematology

Volumn 93, Issue 1, 2011, Pages 47-52

  Ito Habe, Naomi ^a   Wada, Hideo ^a   Matsumoto, Takeshi ^b   Ohishi, Kohshi ^b   Toyoda, Hidemi ^a   Ishikawa, Eiji ^a   Nomura, Shinsuke ^a   Komada, Yoshihiro ^a   Ito, Masaaki ^a   Nobori, Tsutomu ^a   Katayama, Naoyuki ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

ADAMTS13; TM; TMA; Vascular endothelial cell injury; VWFpp

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SURVIVOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE; THROMBOMODULIN; THROMBOTIC MICROANGIOPATHIES; VON WILLEBRAND FACTOR;

EID: 78751571247     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0732-4     Document Type: Article

References (24)

1. JL Moake 2002 Thrombotic microangiopathies N Engl J Med 347 589 600 1:CAS:528:DC%2BD38Xmt1yit7Y%3D 10.1056/NEJMra020528 12192020
2. RM Bukowski 1982 Thrombotic thrombocytopenic purpura: a review Rev Prog Hemost Thromb 6 287 337 1:STN:280:DyaL3s7ntVKksg%3D%3D
3. EL Amorosi JE Ultman 1966 Thrombotic thrombocytopenic purpura: report of the 16 cases and review of the literature Medicine 45 139 159 10.1097/00005792-196603000-00003
4. K Soejima N Mimura M Hirashima H Maeda T Hamamoto T Nakagaki C Nozaki 2001 A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the Von Willebrand factor-cleaving protease? J Biochem 130 475 480 1:CAS:528:DC%2BD3MXovVCqtr0%3D 11574066
5. GG Levy WC Nichols EC Lian T Foroud JN McClintick BM McGee AY Yang DR Siemieniak KR Stark R Gruppo R Sarode SB Shurin V Chandrasekaran SP Stabler H Sabio EE Bouhassira JD Upshaw Jr D Ginsburg HM Tsai 2001 Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpula Nature 413 488 494 1:CAS:528:DC%2BD3MXnsFyit70%3D 10.1038/35097008 11586351
6. X Zheng D Chung TK Takayama EM Majerus JE Sadler K Fujikawa 2001 Structure of Von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem 276 41059 41063 1:CAS:528:DC%2BD3MXosVKgsLw%3D 10.1074/jbc.C100515200 11557746
7. M Furlan R Robles B Lamie 1996 Partial purification and characterization of a protease from human plasma cleaving Von Willebrand factor to fragments produced by in vivo proteolysis Blood 87 4223 4234 1:CAS:528:DyaK28XivFGhtb4%3D 8639781
8. H-M Tsai 1996 Physiologic cleavage of Von Willebrand factor by a plasma protease is depend on its conformation and requires calcium ion Blood 87 4235 4244 1:CAS:528:DyaK28XivFGhtb8%3D 8639782
9. K Kokame Y Nobe Y Kokubo A Okayama T Miyata 2005 FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 93 100 1:CAS:528:DC%2BD2MXktVCgtrg%3D 10.1111/j.1365-2141.2005.05420.x 15801961
10. T Kobayashi H Wada Y Kamikura T Matsumoto Y Mori T Kaneko T Nobori M Matsumoto Y Fujimura H Shiku 2007 Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura Thromb Res 119 447 452 1:CAS:528:DC%2BD2sXhtVCmt7s%3D 10.1016/j.thromres.2006.04.007 16797677
11. DD Wagner 1990 Cell biology of Von Willebrand factor Annu Rev Cell Biol 6 217 246 1:CAS:528:DyaK3MXit1Kiur0%3D 10.1146/annurev.cb.06.110190.001245 2275814
12. A Borchiellini K Fijnvandraat JW ten Cate, et al. 1996 Quantitative analysis of Von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-d-vasopressin in humans Blood 88 2951 2958 1:CAS:528:DyaK28XmtlWjt7Y%3D 8874191
13. AB Federici 2006 VWF propeptide: a useful marker in VWD Blood 108 3229 3230 1:CAS:528:DC%2BD28Xht1ahs7bJ 10.1182/blood-2006-09-043117
14. H Wada M Ohiwa T Kaneko S Tamaki M Tanigawa S Shirakawa M Koyama T Hayashi K Suzuki 1992 Plasma Thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation Am J Hematol 39 20 24 1:STN:280:DyaK387mtVOltA%3D%3D 10.1002/ajh.2830390106 1311143
15. H Wada T Kaneko M Ohiwa M Tanigawa T Hayashi S Tamaki N Minami Katsumi Deguchi K Suzuki T Nakano S Shirakawa 1993 Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura Am J Hematol 44 101 105 1:STN:280:DyaK2c%2FptFaktQ%3D%3D 10.1002/ajh.2830440206 8266913
16. Y Mori H Wada EC Gabazza N Minami T Nobori H Shiku H Yagi H Ishizashi M Matsumoto Y Fujimura 2002 Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity Transfusion 42 572 580 1:CAS:528:DC%2BD38Xlt1Kgs7w%3D 10.1046/j.1537-2995.2002.00100.x 12084165
17. JA Hovinga SK Vesely DR Terrell B Lämmle JN George 2010 Survival and relapse in patients with thrombotic thrombocytopenic purpura Blood 115 1500 1511 10.1182/blood-2009-09-243790 20032506
18. N Ito H Wada M Matsumoto Y Fujimura M Murata T Izuno M Sugita Y Ikeda 2009 National questionnaire survey of TMA Int J Hematol 90 328 335 10.1007/s12185-009-0421-3 19760483
19. N Ito-Habe H Wada M Matsumoto Y Fujimura M Murata T Izuno M Sugita Y Ikeda 2010 A second national questionnaire survey of TMA Int J Hematol 92 68 75 10.1007/s12185-010-0599-4 20524095
20. M Matsumoto H Yagi H Ishizashi H Wada Y Fujimura 2004 The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Seminar Hematol 41 68 74 10.1053/j.seminhematol.2003.10.009
21. Y Fujimura M Matsumoto 2010 Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008 Intern Med 49 7 15 10.2169/internalmedicine.49.2706 20045995
22. EC Lian 2005 Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond Semin Thromb Hemost 31 625 632 1:CAS:528:DC%2BD28XptlSgsA%3D%3D 10.1055/s-2005-925468 16388413
23. JA Kremer Hovinga S Zeerleder P Kessler T Romani de Wit JA van Mourik CE Hack H ten Cate PH Reitsma WA Wuillemin B Lämmle 2007 ADAMTS-13, Von Willebrand factor and related parameters in severe sepsis and septic shock J Thromb Haemost 5 2284 2290 1:STN:280:DC%2BD2snjtlCrtg%3D%3D 10.1111/j.1538-7836. 2007.02743.x 17764538
24. T Ono J Mimuro S Madoiwa K Soejima Y Kashiwakura A Ishiwata K Takano T Ohmori Y Sakata 2006 Severe secondary deficiency of Von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure Blood 107 528 534 1:CAS:528:DC%2BD28Xms1elsA%3D%3D 10.1182/blood-2005-03-1087 16189276